The Guardian 4. maj:
Cuba punches above its weight to develop its own
Covid vaccines
Island hit by biggest economic crisis since the collapse of the Soviet
Union has two vaccines in phase three clinical trials
Hit by the double whammy of US sanctions and a pandemic,
Cuba
is going through its gravest
economic crisis since the collapse of the Soviet Union. Pharmacy shelves are barren. People queue
for
hours to buy chicken. It’s hard to find bread.
And yet this island under siege could become the smallest country in the world to develop its own
coronavirus vaccines. Of the 27 coronavirus vaccines in final stage testing around the world,
two
are Cuban.
“To have our sovereignty we need our own vaccines,” said Dr Vicente Vérez, director of the Finlay
Institute, which has developed Sovereign
2, the most advanced of the country’s five vaccine
candidates. “In nine months we have gone from an idea to a vaccine in phase three clinical trials.”
About 44,000 volunteers in Havana are currently participating in phase three trials for Sovereign 2.
A similar number in the eastern city of Santiago are volunteering for phase three for Abdala, a
vaccine named after a poem by José Martí, the island’s official “national hero”.
Running alongside the clinical studies is an “interventional study” in which 150,000
health workers
in Havana are now being vaccinated.
Cuba’s “biological front” was established in 1981 –
just five years after the incorporation of the
world’s first biotech company, Genentech. At the heart of today’s drive for a vaccine are the island’s
top scientists, many of whom were trained in the former Soviet Union. These internationally mobile
polyglots have every opportunity to emigrate (and many do); those who chose to work on the island
are almost invariably old school believers.
Advertisement
At a recent press conference Dr Vérez explained what drives him by quoting Ernesto “Ché”
Guevara. “The true revolutionary,” he said, “is guided by a great feeling of love”.
Dr Gerardo Guillén, who heads up development of two vaccines at the Center for Genetic
Engineering and Biotechnology, is a chocoholic who has had to do without his favourite fix for over